Skip to main content
OpenTrials

Clinical trial condition

Recurrent World Health Organization (WHO) Grade II Glioma

Explore clinical trials studying Recurrent World Health Organization (WHO) Grade II Glioma. Study availability and eligibility vary by location and protocol.

3 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Recurrent World Health Organization (WHO) Grade II Glioma trial results

Recruiting

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

NCT04485559

Conditions
Glioma, High Grade Glioma, Low-grade Glioma, +8 more
Locations
  • University of Alabama at Birmingham, Children's of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California, San Diego Rady Children's Hospital San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 17 locations
View Trial Details

Related conditions